The European Medicines Agency (EMA) announced further details on its move from current London headquarters to Amsterdam under the ‘phase 4’ of its business continuity plan.
The physical move to the Spark temporary premises in Amsterdam will occur on the week starting Today. From 4 to 8 March, the EMA will operate on the basis of extended teleworking. All EMA staff will gradually move into the Spark building over the course of the following week (11-15 March). After 15 March, all Agency meetings will take place in the new premises in south Amsterdam.
The agency previously announced how the move has an impact on staff numbers, as up to 25% of its workforce will not go to Amsterdam. This reduction will likely reduce the operations at the agency. The EMA will review which activities will be resumed in the second half of 2019 once the move is completed in April.
